Tokyo company DriveX said on 2 October 2026 it raised a total of about 150 million yen from operating companies and individual investors to develop its AI production-planning product for factories.
mutex raises ¥281.6 million Series A for Reze, AI that checks Japanese medical fee claims
EditorialBy TrustList Editorial
Tokyo company mutex announced a ¥281.6 million Series A on 30 September 2026 for Reze, AI that checks hospitals’ medical fee claims for missed items and errors. An English headline gave ¥2.8 billion; the company states ¥281.6 million.
- Japan
- Tokyo, Japan
- Asia
- Medical Billing Software
- +3 more
About mutex raises ¥281.6 million Series A for Reze, AI that checks Japanese medical fee claims
mutex raises ¥281.6 million Series A for Reze, AI that checks Japanese medical fee claims
30 September 2026: mutex Inc., a Tokyo company, announced on 30 September 2026 a Series A round totalling ¥281.6 million (2億8160万円), according to its own release on PR TIMES. It puts its cumulative funding at ¥341.6 million.
The round
- Amount and stage: ¥281.6 million, Series A.
- Investors named by the company: three investors, among them MEDIPAL Innovation Investment LPS, the corporate venture fund of Medipal Holdings, a large Japanese pharmaceutical wholesaler.
- Use of the money: to expand paid adoption among medical institutions and speed up product development towards fully automating claim billing.
What the company does
In Japan, hospitals and clinics bill public health insurance through monthly medical fee statements, known as receipts (レセプト). Errors and missed billable items cost providers revenue, and checking them is labour-intensive. mutex's product, Reze, works with a medical institution's existing systems, reads the claim data and flags items that could have been billed but were missed, as well as deficiencies that could lead to rejection.
Why it matters for buyers
Japanese medical institutions face staff shortages in medical administration and continuing revisions to fee schedules. Tools that check claims without replacing the electronic medical record or billing system can be adopted with less disruption. The involvement of a pharmaceutical wholesaler's fund suggests a possible route to hospitals through an existing distributor.
What to check
- Hospital administrators should ask which electronic medical record and billing systems Reze reads from, how patient data is handled under Japan's personal information rules and the health ministry's security guidelines, and how its suggestions are reviewed before submission.
- Finance teams should measure recovered revenue in a pilot against current manual checking.
Company profile on TrustList: mutex
Related on TrustList:
- Henry raises 1.2 billion yen from regional banks for hospital software
- Rivio raises R$180m to run Brazilian hospitals' billing with AI agents
Sources
- mutex Inc. (PR TIMES): Series A funding announcement for Reze - 30 September 2026
- The Bridge: mutex raises funding in Series A for AI receipt processing support Reze (amount in headline differs from the company’s release) - 1 October 2026
- Sogyo Techo - 1 October 2026
Categories & features
- Japan
- Tokyo, Japan
- Asia
- Medical Billing Software
- Medical Billing
- Artificial Intelligence Software
- Venture Capital
TrustList Weekly
The week in software and IT, in one email
The news that matters to buyers, new rankings and our own research. Every Thursday, free, and easy to leave.
You may be interested in
Tokyo company AIONA announced ¥140 million of funding on 24 September 2026 for REVY, an AI agent for manufacturing design work. The total combines J-KISS convertible equity led by ON&BOARD with bank loans from Aichi Bank and Mizuho Bank.
Shizuoka Bank arranged 1.1 billion yen of the round as a syndicated loan from five regional banks; two bank-linked venture funds added 100 million yen of equity.
Grants and start-up funds for software, AI, robotics, EV and deep tech firms in Japan, South Korea, Thailand, Australia, Singapore, Malaysia, Pakistan and India, closing from 28 October 2026 to January 2027 or open on a rolling basis.
Applications are taken in order of arrival until about 200 matches are made; JPX Research Institute, Ricoh, Nikon and Daiichi Life are among the corporate investors.
Tokyo company QibiTech announced a Series B of about ¥600 million in late September 2026 for HATS, vendor-neutral software that controls robots from different makers and links them to warehouse and factory systems.
A ¥300m final tranche from Sumisho Venture Partners and JA Mitsui Lease's fund brings the Tokyo startup, founded by two former Nissan battery engineers in 2023, to ¥950m raised in total.
JPCERT/CC rates CVE-2026-101020 at 8.5 under CVSS 4.0; Hammock says there is no workaround and that versions before 13.2.0 cannot be upgraded directly.
More on TrustList
Everything here links back to the same verified catalogue. Pick your next stop.
- More JapanThe ranking for this subject
- CompaniesAgencies, consultancies and IT service providers, ranked by verified reviews.
- ProductsSoftware and SaaS with pricing, features, integrations and alternatives.
- AwardsAnnual recognition decided by verified reviews and an independent jury.
- LaunchesNew products and releases, voted up by the community every day.
- AI ModelsBenchmark scores and community ratings for every major model.
- RequestsBuyers describe what they need; vendors respond directly.
- PeopleReviewers, authors and makers with public profiles.
- ComparePut up to four listings side by side before you shortlist.